Cargando…
Investigation of niclosamide as a repurposing agent for skeletal muscle atrophy
Skeletal muscle atrophy is a feature of aging (termed sarcopenia) and various diseases, such as cancer and kidney failure. Effective drug treatment options for muscle atrophy are lacking. The tapeworm medication, niclosamide is being assessed for repurposing to treat numerous diseases, including end...
Autores principales: | Kim, Hyun-Jun, Lee, Ji-Hyung, Kim, Seon-Wook, Lee, Sang-Hoon, Jung, Da-Woon, Williams, Darren R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153455/ https://www.ncbi.nlm.nih.gov/pubmed/34038481 http://dx.doi.org/10.1371/journal.pone.0252135 |
Ejemplares similares
-
Inhibiting 5‐lipoxygenase prevents skeletal muscle atrophy by targeting organogenesis signalling and insulin‐like growth factor‐1
por: Kim, Hyun‐Jun, et al.
Publicado: (2022) -
Lithium Chloride Protects against Sepsis-Induced Skeletal Muscle Atrophy and Cancer Cachexia
por: Lee, Ji-Hyung, et al.
Publicado: (2021) -
Inhibited inositol monophosphatase and decreased myo‐inositol concentration improve wasting in skeletal muscles
por: Lee, Ji‐Hyung, et al.
Publicado: (2020) -
Repurposing niclosamide for the treatment of neurological disorders
por: Apolloni, Savina, et al.
Publicado: (2023) -
Repurposing the anthelmintic drug niclosamide to combat Helicobacter pylori
por: Tharmalingam, Nagendran, et al.
Publicado: (2018)